Share of people with HIV who receive antiretroviral therapy in Sudan
Sudan: Share of people with HIV who receive antiretroviral therapy was 20.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Sudan, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Sudan stood at 20.0%.
Compared with earlier readings it is down 9.1% on the previous year and up 53.8% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Sudan peaked at 28.0% in 2020 and was at its lowest, 0.0%, in 2000.
Sudan ranks 141st of 143 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Sudan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 5.0% | — |
| 2009 | 8.0% | +60.0% |
| 2010 | 8.0% | +0.0% |
| 2011 | 9.0% | +12.5% |
| 2012 | 9.0% | +0.0% |
| 2013 | 12.0% | +33.3% |
| 2014 | 13.0% | +8.3% |
| 2015 | 14.0% | +7.7% |
| 2016 | 17.0% | +21.4% |
| 2017 | 22.0% | +29.4% |
| 2018 | 24.0% | +9.1% |
| 2019 | 27.0% | +12.5% |
| 2020 | 28.0% | +3.7% |
| 2021 | 25.0% | -10.7% |
| 2022 | 24.0% | -4.0% |
| 2023 | 22.0% | -8.3% |
| 2024 | 20.0% | -9.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.3% | 0.0% | 8.0% | 10 |
| 2010s | 15.5% | 8.0% | 27.0% | 10 |
| 2020s | 23.8% | 20.0% | 28.0% | 5 |
Countries ranked near Sudan
More health data for Sudan
- Un projection of annual infant deaths, annual growth rate -1.63 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6701 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 841.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,804 deaths (2100)
- Population ages 75-79, female, annual growth rate 7.06 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0024 units per person (2025)
- Population ages 75-79, male, annual growth rate 5.04 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0028 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Sudan?
- Share of people with hiv who receive antiretroviral therapy in Sudan was 20.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Sudan?
- The highest recorded value was 28.0% in 2020.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Sudan?
- The lowest recorded value was 0.0% in 2000.
- How does Sudan rank for share of people with hiv who receive antiretroviral therapy?
- Sudan ranks 141st out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Sudan?
- Over the last ten years it is up 53.8%. The long-run trend across the full record is volatile.
- Where does this Sudan data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.